TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid
Clinical trial NCT03397173 · COMPLETED
Trial details
- NCT number
- NCT03397173
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-16
- Primary completion
- 2021-01-03
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.